Compare funds
Pick up to 10 funds. Compare funds from the same category for a fair reading.
Growth of ₹10,000
Basics
| SBI Long Term Advantage Fund - Series IV | UTI - Master Equity Plan Unit Scheme | |
|---|---|---|
| Category | ELSS (Tax Saver) | ELSS (Tax Saver) |
| Plan | Regular | Regular |
| Fund house | SBI | UTI |
| NAV | ₹48.0427 | ₹238.7070 |
| NAV date | 20 Nov 2026 | 20 Nov 2026 |
| History | 8.4 years | 20.6 years |
| Expense ratio | 1.4% | 1.4% |
| Stars | ★★★★★ | ★★★★★ |
| Growth Score | 41.70 | 55.20 |
Returns
| SBI Long Term Advantage Fund - Series IV | UTI - Master Equity Plan Unit Scheme | |
|---|---|---|
| 1 month | +9.27% | +11.43% |
| 3 months | +0.92% | +5.89% |
| 6 months | +5.06% | +10.85% |
| YTD | −1.65% | +0.60% |
| 1 year | −1.90% | +0.49% |
| 3 years (CAGR) | +8.57% | +9.80% |
| 5 years (CAGR) | +9.54% | +8.04% |
| 10 years (CAGR) | — | +11.31% |
| Since launch | +17.82% | +9.36% |
Risk
| SBI Long Term Advantage Fund - Series IV | UTI - Master Equity Plan Unit Scheme | |
|---|---|---|
| Volatility | 17.4% | 14.8% |
| Downside volatility | 11.6% | 10.3% |
| Sharpe | 0.12 | 0.22 |
| Sortino | 0.18 | 0.32 |
| Calmar | 0.40 | 0.57 |
| Return / risk | 0.49 | 0.66 |
| Deepest fall | −34.44% | −54.56% |
| Days to recover | 156 | 1869 |
| Below its high | −7.19% | −1.85% |
Against benchmark
| SBI Long Term Advantage Fund - Series IV | UTI - Master Equity Plan Unit Scheme | |
|---|---|---|
| Alpha | −2.49% | −1.34% |
| Beta | 0.97 | 0.88 |
| R² | 80.9% | 92.7% |
| Up capture | 89.5% | 84.0% |
| Down capture | 100.8% | 85.3% |
| Tracking error | 7.6% | 4.4% |
| Information ratio | −0.35 | −0.45 |
| Treynor | 0.01 | 0.03 |
Consistency
| SBI Long Term Advantage Fund - Series IV | UTI - Master Equity Plan Unit Scheme | |
|---|---|---|
| Best 1-year | +113.07% | +86.85% |
| Middle 1-year | +14.15% | +9.02% |
| Worst 1-year | −18.38% | −50.15% |
| 1-year periods with a loss | 15.4% | 25.0% |
| Middle 3-year | +25.45% | +10.78% |
| Positive months | 55.6% | 61.1% |
| Best day | +4.33% | +3.87% |
| Worst day | −4.50% | −4.59% |
| Worst 5% day | −1.43% | −1.27% |
| Positive days | 54.1% | 54.3% |
| NAVs a year | 252 | 247 |
SIP of ₹10,000 a month
| SBI Long Term Advantage Fund - Series IV | UTI - Master Equity Plan Unit Scheme | |
|---|---|---|
| 5-year XIRR | +8.86% | +8.85% |
| 5-year value | ₹7,53,496 | ₹7,53,348 |
| 3-year XIRR | +4.28% | +6.20% |
| 1-year XIRR | +4.32% | +12.08% |
Holdings overlap i
| SBI Long Term Advantage Fund - Series IV | UTI - Master Equity Plan Unit Scheme | |
|---|---|---|
| SBI Long Term Advantage Fund - Series IV | — | 28% |
| UTI - Master Equity Plan Unit Scheme | 28% | — |
Share of money in the same stocks, by weight. Above 50% means much of one fund repeats the other.
Held by all of them
| Stock | SBI Long Term Advantage Fund - Series IV | UTI - Master Equity Plan Unit Scheme |
|---|---|---|
| ICICI Bank Limited | 8.34% | 9.30% |
| Bharti Airtel Limited | 4.60% | 4.95% |
| Kotak Mahindra Bank Limited | 4.20% | 5.12% |
| Bajaj Finance Limited | 7.47% | 3.31% |
| Mahindra & Mahindra Limited | 1.94% | 1.81% |
| State Bank of India | 3.28% | 1.60% |
| Max Healthcare Institute Limited | 3.18% | 1.00% |
| Tech Mahindra Limited | 2.54% | 0.93% |
| Tata Motors Ltd | 3.83% | 0.80% |
| Jindal Stainless Limited | 2.68% | 0.68% |
| Sun Pharmaceutical Industries Limited | 3.53% | 0.50% |
Sectors and company size
| SBI Long Term Advantage Fund - Series IV | UTI - Master Equity Plan Unit Scheme | |
|---|---|---|
| Large companies | 50.1% | 83.8% |
| Mid companies | 14.9% | 7.7% |
| Small companies | 26.8% | 2.0% |
| Top 10 holdings | 48.3% | 50.1% |
| Largest sector | Finance 19% | Banks 28% |